Impact of pharmaceutical care on the health-related quality of life among hemodialysis patients - A multicenter randomized controlled study.

Impact of pharmaceutical care on the health-related quality of life among hemodialysis patients - A multicenter randomized controlled study. Saudi J Kidney Dis Transpl. 2017 Nov-Dec;28(6):1293-1306 Authors: Mateti UV, Nagappa AN, Attur RP, Nagarapu SP, Rangaswamy D Abstract The present study was planned to assess the impact of pharmaceutical care on the health-related quality of life (HRQoL) among hemodialysis (HD) patients. An open-label, randomized control study was carried out at three different HD centers of teaching, government, and corporate hospitals in South India. The patients were randomized into two groups (Usual Care Group [UC] and Pharmaceutical Care Group [PC]) by block design method. The PC group received the normal care along with pharmaceutical care delivered by a qualified registered pharmacist. The assessment of the HRQoL was carried out at baseline, 6th and 12th months for the both groups for a total of 12-month follow-up. A total number of 200 patients were recruited from the three HD centers. At the end of the study, 153 patients were followed. Out of 153 patients, 83 were from academic hospital (UC, n =41; PC, n = 42), 18 from government hospital (UC, n = 09; PC, n = 09), and 52 from corporate hospital (UC, n = 25; PC, n = 27). The HRQoL scores were significantly improved over time in the domains noticed with regard to the "physical functioning, general health, emotional well-being, social functioning, symptom/...
Source: Saudi Journal of Kidney Diseases and Transplantation - Category: Urology & Nephrology Authors: Tags: Saudi J Kidney Dis Transpl Source Type: research